2018-07444. Importer of Controlled Substances Registration  

  • Start Preamble

    ACTION:

    Notice of registration.

    SUMMARY:

    Registrants listed below have applied for and been granted registration by the Drug Enforcement Administration (DEA) as importers of various classes of schedule I or II controlled substances.

    End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    The companies listed below applied to be registered as importers of various basic classes of controlled substances. Information on previously published notices is listed in the table below. No comments or objections were submitted and no requests for hearing were submitted for these notices.

    CompanyFR docketPublished
    Sharp (Bethlehem), LLC83 FR 539January 4, 2018.
    Catalent Pharma Solutions, LLC83 FR 2215January 16, 2018.
    Janssen Pharmaceuticals, Inc83 FR 2214January 16, 2018.
    Mylan Pharmaceuticals, Inc83 FR 5809February 9, 2018.
    Meridian Medical Technologies, Inc83 FR 5810February 9, 2018.
    Noramco, Inc83 FR 5810February 9, 2018.
    Johnson Matthey, Inc83 FR 5811February 9, 2018.
    Mylan Technologies, Inc83 FR 5811February 9, 2018.
    Mylan Pharmaceuticals, Inc83 FR 8107February 23, 2018.

    The Drug Enforcement Administration (DEA) has considered the factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the registration of the listed registrants to import the applicable basic classes of schedule I or II controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated each company's maintenance of effective controls against diversion by inspecting and testing each company's physical security systems, verifying each company's compliance with state and local laws, and reviewing each company's background and history.

    Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the DEA has granted a registration as an importer for schedule I or II controlled substances to the above listed companies.

    Start Signature

    Dated: April 4, 2018.

    Susan A. Gibson,

    Deputy Assistant Administrator.

    End Signature End Supplemental Information

    [FR Doc. 2018-07444 Filed 4-10-18; 8:45 am]

    BILLING CODE 4410-09-P

Document Information

Published:
04/11/2018
Department:
Drug Enforcement Administration
Entry Type:
Notice
Action:
Notice of registration.
Document Number:
2018-07444
Pages:
15633-15633 (1 pages)
Docket Numbers:
Docket No. DEA-392
PDF File:
2018-07444.pdf